Korean kidney study tracks Real-World use of finerenone

This study watches 500 adults in South Korea who have chronic kidney disease and type 2 diabetes and are taking finerenone as part of their normal care. Researchers will collect information from medical records and doctor visits over up to 12 months to see why doctors prescribe it, how long people take it, and what side effects occur. The goal is to learn more about how finerenone works in everyday practice, not to test a new treatment.